Check out page 729+ – article by Strauss et al on the implications of regulations on biofuel crops/development (grasses and woody plants) in US entitled “Far reaching Deleterious Impacts of Regulations on Research & Environmental Studies of Recombinant DNA-modeified Perennial Biofuel Crops in the US”
October 2010, Volume 60 No. 9
“…the current legal and regulatory situation places severe constraints on both the ability to develop GE crops at all, and then on the performance of adequate environmental studies to inform regulatory and other social decisions about their use…” (p. 738).
Strauss etal outline some ways to address the current constraints/problems:
1. focus regulatory requirements on defined risks.
2. use scientific criteria for design of categories for a low-level presence (LLP) system
3. create an early stage LLP management system
4. clarify the role of NEPA and the CBD
According to Strauss etal, “…the regulatory thicket is deep and thorny…” Resolving issues will require reworking of laws (in US and internationally) or “…a fundamental court precedent that stops the penalization of the GE process” and “enshrining into law the ‘product not process’ principle” (p. 739).
“Solving these problems will require new ways of thinking and strong scientific and political leadership to move us toward a regulatory system that enables, rather than arbitrarily blocks, the use of GE as a tool to accelerate and diversify the breeding of … biofuelcrops.” (p.739).
An article from Physorg.com outlines the report by Strauss and colleagues http://www.physorg.com/news205157589.html
Article excerpt: “The current environment poses enormous legal risks that can and have cost some companies millions of dollars in civil lawsuits, the scientists said, sometimes for damages that were more of perception and market issues, than of safety or environmental impact.”
Dr. David Castle*,** Canada Research Chair in Science and Society, University of Ottawa and Diefenbaker Policy Fellow, University of Saskatchewan* gives a talk at the Johnson-Shoyama Graduate School at the University of Saskatchewan, Canada
– explore technology diffusion in a systems context to identify bottlenecks in the regulatory process
– case study: introducing Hep B vaccine to mitigate the infectious disease burden in the developing world
– not a lot of innovative vaccines being introduced right now and they are expensive!
– huge vaccine funding gap
– modelling the problem, developing solutions!